STOCK TITAN

CBIS - $CBIS STOCK NEWS

Welcome to our dedicated page for CBIS news (Ticker: $CBIS), a resource for investors and traders seeking the latest updates and insights on CBIS stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CBIS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CBIS's position in the market.

-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
CBIS

OTC:CBIS

CBIS Rankings

CBIS Stock Data

Biotechnology
Health Technology
Link
US
Irvine

About CBIS

Cannabis Science, Inc. develops cannabis pharmaceutical products. It works on phytocannabinoid science targeting critical illnesses and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. The company was founded by Raymond C. Dabney on February 29, 1996 and is headquartered in Irvine, CA.